Beranda › Penyakit Paru › Minnesota
Uji klinis Penyakit Paru di Minnesota
7 studi untuk Penyakit Paru mencari peserta di lokasi di Minnesota.
Kota di Minnesota
Teks studi resmi (Bahasa Inggris)
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Saint Paul
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05624450A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Headlands Research-Twin Cities, Maplewood
Menerima pesertaFase 2
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07759245A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Allina Health Cancer Institute - Abbott Northwestern Hospital, Minneapolis
- HealthPartners Cancer Research Center, Saint Paul
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06119581A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 108, Rochester
Menerima pesertaFase 3
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT07555483Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
- University of Minnesota, Minneapolis
Menerima pesertaFase 2
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 26 Jun 2026 · NCT04614103Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
- Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Feb 2026 · NCT02984761Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
- University of Minnesota, Minneapolis
- Mayo Clinic, Rochester
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2025 · NCT04555161Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.